New disease found in drug users: researchers race to understand it
NCT ID NCT06573671
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This observational study looks at a newly identified lung condition called histiocytosis in people who inject drugs. Researchers will study 30 patients to understand symptoms, diagnosis, and outcomes. They will also test new ways to detect a substance called polyvinylpyrrolidone (PVP) that may cause the condition. The goal is to improve diagnosis and distinguish it from other similar diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better diagnose and understand a rare lung condition linked to injecting crushed tablets.
- What could go wrong
- This is a small, early observational study with only 30 participants, so findings may not apply broadly. It aims to describe the condition, not test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HISTIOCYTOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tampere University Hospital
Tampere, Pirkanmaa, 33101, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive study tracks hidden toll of rare immune diseases
- Rare disease study probes hidden brain effects
- New hope for kids with rare blood cancer: targeted drug trial launches
- New hope for kids with rare blood disorder: trametinib trial launches
- New imaging test could spot rare childhood disease sooner
- Promising combo aims to tame relapsed childhood cancers